inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: * men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay * men ≥ 18 years but \< 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. * access to working telephone or other form of communication such as email. * randomization within 7 days of covid-positive study result. all subjects will undergo repeat covid-19 assay on day 0 enrollment and a positive test is required to stay on study * written informed consent obtained from the subject and the subject agrees to comply with all study-related procedures

inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: * men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay * men ≥ 18 years but \< 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. * access to working telephone or other form of communication such as email. * randomization within 7 days of covid-positive study result. all subjects will undergo repeat covid-19 assay on day 0 enrollment and a positive test is required to stay on study * written informed consent obtained from the subject and the subject agrees to comply with all study-related procedures

inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: - men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay - men ≥ 18 years but < 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. - access to working telephone or other form of communication such as email. - randomization within 7 days of covid-positive study result. all subjects will undergo repeat covid-19 assay on day 0 enrollment and a positive test is required to stay on study - written informed consent obtained from the subject and the subject agrees to comply with all study-related procedures

inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: - men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay - men ≥ 18 years but < 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. - access to working telephone or other form of communication such as email. - randomization within 7 days of covid-positive study result. all subjects will undergo repeat covid-19 assay on day 0 enrollment and a positive test is required to stay on study - written informed consent obtained from the subject and the subject agrees to comply with all study-related procedures

inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: - men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay - men ≥ 18 years but < 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. - access to working telephone or other form of communication such as email. - randomization within 7 days of covid-positive study result and

inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: - men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay - men ≥ 18 years but < 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. - access to working telephone or other form of communication such as email. - randomization within 7 days of covid-positive study result and

inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: - a. men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay - b. men ≥ 18 years but < 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. - c. access to working telephone or other form of communication such as email. - d. randomization within 48 hours of covid-positive study result and - e. written informed consent obtained from the subject and the subject agrees to comply with all study-related procedures.

inclusion criteria: subjects must meet all of the following criteria to be eligible for study participation: - a. men ≥ 36 years old diagnosed with at least one temperature elevation ≥ 100.4 f., or new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay - b. men ≥ 18 years but < 36 years old must exhibit either new cough, or new dyspnea and documented covid-19 positive by approved standard local laboratory assay. - c. access to working telephone or other form of communication such as email. - d. randomization within 48 hours of covid-positive study result and - e. written informed consent obtained from the subject and the subject agrees to comply with all study-related procedures.